Skip to main content
. Author manuscript; available in PMC: 2011 Oct 1.
Published in final edited form as: Head Neck. 2010 Oct;32(10):1412–1421. doi: 10.1002/hed.21365

Figure 3.

Figure 3

The mutant epidermal growth factor receptor, EGFRvIII, promotes cell survival and proliferation by preferential signaling through the phosphotidyinositol-3-kinase (PI3K) pathway. The wild-type receptor utilizes both the PI3K pathway and the Ras-Raf-MEK pathway. Downstream effectors of both pathways further promote cell survival via inhibition of apoptosis.